These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 25569001

  • 1. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
    Mahnert N, Morgan D, Campbell D, Johnston C, As-Sanie S.
    Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
    Topdagi Yilmaz EP, Cimilli Senocak GN, Topdagi YE, Aynaoglu Yildiz G, Kumtepe Y.
    J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
    [Abstract] [Full Text] [Related]

  • 5. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
    Kho KA, Lin K, Hechanova M, Richardson DL.
    Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
    Desai VB, Wright JD, Gross CP, Lin H, Boscoe FP, Hutchison LM, Schwartz PE, Xu X.
    Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
    [Abstract] [Full Text] [Related]

  • 8. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
    Parsons LHP, Pedersen R, Richardson DL, Kho KA.
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
    [Abstract] [Full Text] [Related]

  • 9. Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative.
    Corona LE, Swenson CW, Sheetz KH, Shelby G, Berger MB, Pearlman MD, Campbell DA, DeLancey JO, Morgan DM.
    Am J Obstet Gynecol; 2015 Mar; 212(3):304.e1-7. PubMed ID: 25542564
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical Complex.
    AbuSaqer SM, Shammala AIHA, Elejla S, Mahdi H, Laban RA, Hamada HA, Zimmo MW.
    Cancer Treat Res Commun; 2023 Mar; 35():100697. PubMed ID: 36989579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
    Cui RR, Wright JD.
    Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
    Mettler L, Abdusattarova K, Alkatout I.
    Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain.
    Mowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, As-Sanie S.
    Obstet Gynecol; 2016 Jun; 127(6):1045-1053. PubMed ID: 27159755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.